If Companies Are Leaving China, Where Are They Going, And Why?
Dan Harris, international lawyer at Harris Bricken and founding author of the China Law Blog talks about companies leaving China. Are any coming here?
Inflation Reduction Act Brings Solar Investments to the US. WSJ Unimpressed.
Companies continue to invest in domestic solar thanks to all the new renewable energy tax credits. Without them, and tariffs, US solar would be China owned.
Candidate Trump Announces Plans to Reshore Essential Medicines to Avoid Drug Shortages
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
House Committee on the CCP Says China Risks are Rising for American Companies
Big trouble in China as Washington increasingly warns American businesses to “stay at your own risks”.
So Much For China ‘Thaw’. Treasury Secretary Yellen Says China Tariffs Will Remain
Tariffs — and China risks — have helped U.S. reshore and led to more investments in production, shifting the decades old focus away from offshoring.
Economic Conference Asks “What Would (Alexander) Hamilton Do?”
Alexander Hamilton advocated for trade tariffs and strong IP protections to build the U.S. economy and protect it from more powerful, or more devious adversaries. A debate in DC over whether we are heading towards Hamiltonian economics.
European Pharma Considers Reshoring from India, China. Where’s the US?
The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
Supply Chain Dependence Makes Reshoring Harder – McKinsey
Can the U.S. really bring manufacturing home? A McKinsey study shows that existing concentration of some supply chains will make it hard. Here’s what needs to be done.
Repealing China’s Most Favored Nation Status: A Guide
By Charles Benoit, CPA Trade Counsel In December, the U.S.-China Commission, a group created by Congress to advise on managing the bilateral relationship, formally recommended that China lose its Most-Favored Nation (MFN) tariff status. Referencing the decision to grant China permanent MFN status in 2001, Speaker McCarthy said in remarks on the House floor yesterday…
Senate Hearing Bemoans Worker Shortages, Wonders If Reshoring Can Work
A Senate Commerce subcommittee hearing heard from witnesses who said worker shortages will ultimately be a drag on U.S. reshoring efforts. Pharmaceutical reps warned of high energy costs, which could add to import dependence.